We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer.
- Authors
Arellano-Garcia, Martha E.; Roger Li; Xiaojun Liu; Yongming Xie; Xiaofei Yan; Loo, Joseph A.; Shen Hu
- Abstract
Lymph node involvement is the most important predictor of survival rates in patients with oral squamous cell carcinoma (OSCC). A biomarker that can indicate lymph node metastasis would be valuable to classify patients with OSCC for optimal treatment. In this study, we have performed a serum proteomic analysis of OSCC using 2-D gel electrophoresis and liquid chromatography/tandem mass spectrometry. One of the down-regulated proteins in OSCC was identified as tetranectin, which is a protein encoded by the CLEC3B gene (C-type lectin domain family 3, member B). We further tested the protein level in serum and saliva from patients with lymph-node metastatic and primary OSCC. Tetranectin was found significantly under-expressed in both serum and saliva of metastatic OSCC compared to primary OSCC. Our results suggest that serum or saliva tetranectin may serve as a potential biomarker for metastatic OSCC. Other candidate serum biomarkers for OSCC included superoxide dismutase, ficolin 2, CD-5 antigen-like protein, RalA binding protein 1, plasma retinol-binding protein and transthyretin. Their clinical utility for OSCC detection remains to be further tested in cancer patients.
- Subjects
METASTASIS; CANCER; BIOMARKERS; CANCER treatment; LYMPH node cancer; PROTEOMICS; MOLECULAR biology; ELECTROPHORESIS
- Publication
International Journal of Molecular Sciences, 2010, Vol 11, Issue 9, p3106
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms11093106